Reaction
Retinal Exudates reporting signals
As of the last recalculation, Retinal Exudates appears in 924 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 146.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 146 | 146.9 | 147.8 |
| Aflibercept | 61 | 47.1 | 47.2 |
| Ribavirin | 98 | 38.3 | 38.3 |
| Peginterferon Alfa-2A | 80 | 36.4 | 36.5 |
| Faricimab | 12 | 33.8 | 33.8 |
| Thiotepa | 9 | 21.4 | 21.4 |
| Bevacizumab | 72 | 14.1 | 14.1 |
| Timolol | 7 | 13.1 | 13.1 |
| Efavirenz | 6 | 12.2 | 12.2 |
| Cladribine | 5 | 11.8 | 11.8 |
| Sofosbuvir | 6 | 6.9 | 6.9 |